1. Home
  2. MBWM vs AMPH Comparison

MBWM vs AMPH Comparison

Compare MBWM & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mercantile Bank Corporation

MBWM

Mercantile Bank Corporation

HOLD

Current Price

$53.87

Market Cap

928.7M

Sector

Finance

ML Signal

HOLD

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

HOLD

Current Price

$18.79

Market Cap

971.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MBWM
AMPH
Founded
1997
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
928.7M
971.8M
IPO Year
1997
2005

Fundamental Metrics

Financial Performance
Metric
MBWM
AMPH
Price
$53.87
$18.79
Analyst Decision
Buy
Buy
Analyst Count
3
8
Target Price
$55.67
$28.38
AVG Volume (30 Days)
121.3K
614.5K
Earning Date
04-21-2026
05-07-2026
Dividend Yield
3.08%
N/A
EPS Growth
10.95
N/A
EPS
1.32
0.14
Revenue
N/A
$719,887,000.00
Revenue This Year
$20.28
$6.90
Revenue Next Year
$4.67
$4.64
P/E Ratio
$40.25
$139.07
Revenue Growth
N/A
N/A
52 Week Low
$42.69
$16.65
52 Week High
$55.77
$31.26

Technical Indicators

Market Signals
Indicator
MBWM
AMPH
Relative Strength Index (RSI) 53.98 45.67
Support Level $50.02 $18.92
Resistance Level $54.00 $19.81
Average True Range (ATR) 1.46 0.76
MACD 0.04 0.08
Stochastic Oscillator 61.10 41.78

Price Performance

Historical Comparison
MBWM
AMPH

About MBWM Mercantile Bank Corporation

Mercantile Bank Corp operates as a bank holding company. It offers various commercial banking services to individuals, businesses, governmental units, and other institutions. These services include deposit products such as checking, savings, and term certificate accounts and lending products such as commercial, residential mortgage, and installment loans. The company generates revenue from interest and dividends earned on loans, securities, and other financial instruments.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: